Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period
Clinical trial NCT02531269 · COMPLETED
Trial details
- NCT number
- NCT02531269
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-02-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.